Clinical Trial Update: First Time in Human Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and the Effect of Food of Single Assending Doses of GSK1482160. [Phase 1]

View source ↗

Summary

Phase 1 first-in-human study evaluating safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of GSK1482160, including the effec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Disease
• Pain

Drugs mentioned

• GSK1482160

Snippet

Sponsor: GlaxoSmithKline | Conditions: Pain, Inflammatory | Phase 1 | Status: COMPLETED